{"count": 3, "results": [{"_id": "30703842", "pmid": 30703842, "title": "[Hemiballism-Hemichorea Induced by Non-Ketotic Hyperglycemia].", "journal": "Dtsch Med Wochenschr", "authors": ["Meyer T", "Dafotakis M"], "date": "2019-02-01T00:00:00Z", "doi": "10.1055/a-0815-5911", "meta_date_publication": "2019 Feb", "meta_volume": "144", "meta_issue": "3", "meta_pages": "203-206", "score": 50064.906, "text_hl": "[@<m>DISEASE_Dyskinesias</m> @DISEASE_MESH:D020820 @@@Hemiballism@@@-Hemichorea Induced by @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@Non-Ketotic Hyperglycemia@@@].", "citations": {"NLM": "Meyer T, Dafotakis M. [Hemiballism-Hemichorea Induced by Non-Ketotic Hyperglycemia]. Dtsch Med Wochenschr. 2019 Feb;144(3):203-206. PMID: 30703842", "BibTeX": "@article{30703842, title={[Hemiballism-Hemichorea Induced by Non-Ketotic Hyperglycemia].}, author={Meyer T and Dafotakis M}, journal={Dtsch Med Wochenschr}, volume={144}, number={3}, pages={203-206}}"}}, {"_id": "22861817", "pmid": 22861817, "title": "Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin.", "journal": "J Oral Pathol Med", "authors": ["Patel H", "Younis RH", "Ord RA", "Basile JR", "Schneider A"], "date": "2013-03-01T00:00:00Z", "doi": "10.1111/j.1600-0714.2012.01196.x", "meta_date_publication": "2013 Mar", "meta_volume": "42", "meta_issue": "3", "meta_pages": "250-6", "score": 50052.285, "text_hl": "Moreover, in @<m>DISEASE_Dyskinesias</m> @DISEASE_MESH:D020820 @@@oral dysplasias@@@, high @GENE_SLC22A3 @GENE_6581 @@@OCT-3@@@ expression localized to epithelial compartments where mTORC1 signaling was also upregulated suggestive of a potential local effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Patel H, Younis RH, Ord RA, Basile JR, Schneider A. Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin. J Oral Pathol Med. 2013 Mar;42(3):250-6. PMID: 22861817", "BibTeX": "@article{22861817, title={Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin.}, author={Patel H and Younis RH and Ord RA and Basile JR and Schneider A}, journal={J Oral Pathol Med}, volume={42}, number={3}, pages={250-6}}"}}, {"_id": "29039022", "pmid": 29039022, "title": "Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease.", "journal": "Mol Neurobiol", "authors": ["Ryu YK", "Park HY", "Go J", "Choi DH", "Kim YH", "Hwang JH", "Noh JR", "Lee TG", "Lee CH", "Kim KS"], "date": "2018-07-01T00:00:00Z", "doi": "10.1007/s12035-017-0752-7", "meta_date_publication": "2018 Jul", "meta_volume": "55", "meta_issue": "7", "meta_pages": "5715-5726", "score": 50051.42, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ showed a long-lasting effect on axial, limb, and @<m>DISEASE_Dyskinesias</m> @DISEASE_MESH:D020820 @@@orofacial abnormal involuntary movement@@@ scores for up to 20 days after treatment initiation. ", "citations": {"NLM": "Ryu YK, Park HY, Go J, Choi DH, Kim YH, Hwang JH, Noh JR, Lee TG, Lee CH, Kim KS. Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease. Mol Neurobiol. 2018 Jul;55(7):5715-5726. PMID: 29039022", "BibTeX": "@article{29039022, title={Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease.}, author={Ryu YK and Park HY and Go J and Choi DH and Kim YH and Hwang JH and Noh JR and Lee TG and Lee CH and Kim KS}, journal={Mol Neurobiol}, volume={55}, number={7}, pages={5715-5726}}"}}]}